JW Pharmaceutical Corporation (KRX:001065)

JW Pharmaceutical Statistics

Total Valuation

KRX:001065 has a market cap or net worth of KRW 600.19 billion. The enterprise value is 586.35 billion.

Market Cap	600.19B
Enterprise Value	586.35B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Current Share Class	337,418
Shares Outstanding	n/a
Shares Change (YoY)	-6.67%
Shares Change (QoQ)	-5.66%
Owned by Insiders (%)	0.81%
Owned by Institutions (%)	8.29%
Float	12.90M

Valuation Ratios

The trailing PE ratio is 10.25.

PE Ratio	10.25
Forward PE	n/a
PS Ratio	0.79
PB Ratio	1.69
P/TBV Ratio	1.75
P/FCF Ratio	7.69
P/OCF Ratio	6.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.98, with an EV/FCF ratio of 7.51.

EV / Earnings	10.02
EV / Sales	0.77
EV / EBITDA	4.98
EV / EBIT	5.92
EV / FCF	7.51

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.19.

Current Ratio	1.51
Quick Ratio	0.94
Debt / Equity	0.19
Debt / EBITDA	0.59
Debt / FCF	0.88
Interest Coverage	9.70

Financial Efficiency

Return on equity (ROE) is 19.09% and return on invested capital (ROIC) is 14.12%.

Return on Equity (ROE)	19.09%
Return on Assets (ROA)	9.74%
Return on Invested Capital (ROIC)	14.12%
Return on Capital Employed (ROCE)	24.86%
Revenue Per Employee	715.55M
Profits Per Employee	54.80M
Employee Count	1,068
Asset Turnover	1.22
Inventory Turnover	3.54

Taxes

In the past 12 months, KRX:001065 has paid 27.20 billion in taxes.

Income Tax	27.20B
Effective Tax Rate	30.23%

Stock Price Statistics

The stock price has decreased by -1.42% in the last 52 weeks. The beta is 1.03, so KRX:001065's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-1.42%
50-Day Moving Average	27,506.00
200-Day Moving Average	28,505.25
Relative Strength Index (RSI)	58.10
Average Volume (20 Days)	123

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:001065 had revenue of KRW 764.21 billion and earned 58.53 billion in profits. Earnings per share was 2,533.07.

Revenue	764.21B
Gross Profit	352.45B
Operating Income	97.31B
Pretax Income	89.99B
Net Income	58.53B
EBITDA	116.05B
EBIT	97.31B
Earnings Per Share (EPS)	2,533.07

Balance Sheet

The company has 82.51 billion in cash and 68.66 billion in debt, giving a net cash position of 13.85 billion.

Cash & Cash Equivalents	82.51B
Total Debt	68.66B
Net Cash	13.85B
Net Cash Per Share	n/a
Equity (Book Value)	354.10B
Book Value Per Share	14,667.25
Working Capital	111.85B

Cash Flow

In the last 12 months, operating cash flow was 87.80 billion and capital expenditures -9.77 billion, giving a free cash flow of 78.02 billion.

Operating Cash Flow	87.80B
Capital Expenditures	-9.77B
Free Cash Flow	78.02B
FCF Per Share	n/a

Margins

Gross margin is 46.12%, with operating and profit margins of 12.73% and 8.22%.

Gross Margin	46.12%
Operating Margin	12.73%
Pretax Margin	11.78%
Profit Margin	8.22%
EBITDA Margin	15.19%
EBIT Margin	12.73%
FCF Margin	10.21%

Dividends & Yields

This stock pays an annual dividend of 475.00, which amounts to a dividend yield of 1.71%.

Dividend Per Share	475.00
Dividend Yield	1.71%
Dividend Growth (YoY)	11.76%
Years of Dividend Growth	6
Payout Ratio	17.63%
Buyback Yield	6.67%
Shareholder Yield	8.38%
Earnings Yield	9.75%
FCF Yield	13.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

KRX:001065 has an Altman Z-Score of 3.71 and a Piotroski F-Score of 7.

Altman Z-Score	3.71
Piotroski F-Score	7